Choosing between soft tooling and production tooling matters as much as material selection does for a medical device moving toward its first production run. Soft tooling uses aluminium or unhardened steel moulds, production tooling uses hardened steel, and neither is the automatic right answer. It comes down to volume, timeline, and how settled the design actually is.

For a device with a clinical trial or field-test deadline approaching, and final production volume not yet confirmed, that usually points toward soft tooling: parts in production-intent material, without the cost or lead time a hardened tool demands.

Marcopolo supports medical-device companies from concept to production: prototyping, soft tooling, production tooling, injection moulding, assembly, and low-volume manufacturing. 

Soft tooling uses aluminium or un-hardened steel moulds to produce injection-moulded parts. These materials can be machined faster than hardened tool steel, allowing a tool to be built or modified while the design is still evolving.

Soft tooling delivers functional prototypes and low-volume production in production-intent material, with tool life up to 50,000 shots and a lead time of 2 to 6 weeks, at roughly half the cost and lead time of production tooling.

For medical devices, tooling decisions cannot be separated from material selection. Marcopolo processes engineering and high-performance polymers in biocompatible grades: PP (medical grade homopolymer) for syringes and flexible hinges, ABS and PC-ABS for housings, PC (Makrolon Rx grades) for transparent covers and high-strength housings, TPU (Pellethane, Tecoflex) for seals and flexible components, PPSU (Radel PPSU) for repeat-sterilisation instrument housings, and ULTEM (USP Class VI, Ultem 1010) for high-performance sterilisable housings.

The right grade should be confirmed against the device’s sterilisation method, load, and intended use before it’s specified in any document. 

Soft tooling supports fast validation and smaller first production runs. Hard tooling is designed for durable, sustained production after the design and process are stable.

The lead times and tool-life figures above are planning references from the draft, not universal guarantees. Final values depend on part size, geometry, material, tool design, finish, machine, and inspection requirements.

Soft tooling is valuable when a medical-device team needs:

• Functional prototypes and pilot batches in the actual production material.
• Clinical or field-test batches before the design is fully frozen.
• Low-volume production from hundreds to thousands of units.
• Design and manufacturability validation before committing to a hardened tool.
• A first production run while demand is still being established.
• Reduced upfront tooling investment for early market supply.

Marcopolo’s medical-device capability includes cost-efficient soft tools engineered with production intent and flexible MOQs to match market demand.

A common route is to launch the first production batch with a soft tool while the hardened production tool is built in parallel. This can supply the early market without waiting for the complete production tooling programme.

When the production tool comes online, the changeover should be treated as a controlled tool transfer—not a simple swap. Compare the original and new parts for:

• Critical dimensions and tolerances.
• Material grade and processing conditions.
• Surface finish and visible parting lines.
• Fit, function, and assembly.
• Shrinkage, warpage, and critical features.
• First-article inspection results.
• Documentation and engineering-change records.

A change in tooling can alter cooling, shrinkage, gate design, surface finish, and process parameters. The new tool may therefore require additional qualification or validation within the device quality system.

Soft tooling and production tooling solve different problems. Soft tooling, in aluminium or mild steel, is built for validation, pilot batches, and early production, low tool cost, high design flexibility, and a tool life of hundreds to low thousands of shots. Production tooling, in hardened steel, is built for committed, high-volume production, holding up past 100,000 shots.

Neither is a lesser version of the other. Each is built for the stage it’s meant for, the design’s maturity and the volume actually needed decide which one fits.

Soft tooling sits in the middle of the journey from concept to production. Earlier stages, 3D printing, vacuum casting, and RIM, validate form, fit, and functional behaviour before a design is fully settled. Soft tooling takes over once a design needs production-intent material in real, testable batches, for pilot runs, regulatory submissions, and early production. Production tooling takes over once demand is established and the design is final.

Marcopolo supports every stage of this journey under one roof, from first concept to production launch.

The decision between soft tooling vs hard tooling should follow the device’s maturity, material, sterilisation method, quantity, validation plan, and expected production life.

Soft tooling is often the practical choice when a medical-device manufacturer needs production-intent parts for clinical or field testing, pilot supply, or a first production run before demand is established. Hard tooling becomes more appropriate when the design is stable, the process is qualified, and sustained production justifies the higher investment.

A successful programme plans the transition early, confirms the material against sterilisation requirements, compares parts made from both tools, and documents every engineering, inspection, and process change.